Status:
COMPLETED
China Antiretroviral Treatment Adherence for Life
Lead Sponsor:
Boston University
Collaborating Sponsors:
Beijing Ditan Hospital
Second People's Hospital, Dali
Conditions:
HIV Infections
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study focuses on collecting and analyzing quantitative data related to adherence to antiretroviral treatment from patients in Dali, China, over a one-year time-frame and generating preliminary da...
Detailed Description
This study is a continuation of "Adherence for Life (AFL): Phase I: Exploratory Research" (H-25203), which focused on collecting and analyzing qualitative data on adherence to antiretroviral treatment...
Eligibility Criteria
Inclusion
- Patients who are 18 years of age or older, currently on antiretroviral treatment or about to begin it, live in the study catchment area, and are willing to provide informed consent.
Exclusion
- Persons below the age of 18 years, persons who are not currently on or about to start antiretroviral treatment, persons who live outside the study catchment area, or person not willing to provide informed consent.
Key Trial Info
Start Date :
June 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2007
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT00661258
Start Date
June 1 2006
End Date
November 1 2007
Last Update
May 15 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dali Second People's Hospital
Dali, Yunnan, China